Coronary Stents Industry Growth By Type, Mode of Delivery - Forecast 2021

Major factors driving the growth of this market include technological advancements, increasing demand for minimally invasive procedures, rising burden of CAD, increasing number of percutaneous coronary intervention (PCI) procedures and rising geriatric population.

According to research report Coronary Stents Market is expected to reach $10.31 billion by 2021, at a CAGR of 7.6% from 2016 to 2021.

Based on type, the market is segmented into bare-metal stents, drug-eluting stents and bioabsorbable stents. The drug-eluting stents segment is expected to account for the largest share of the coronary stents market. This can primarily be attributed to the advantages of drug-eluting stents over bare-metal stents, such as lower risk of restenosis and other related complications.

Based on mode of delivery, the Coronary Stents Market is segmented into balloon-expandable stents and self-expanding stents. The balloon expandable stents segment is expected to grow at the highest CAGR during the forecast period due to factors such as high utilization of these stents, increasing research activities to improve this technology and growing regulatory approvals for balloon-expandable stents.

The Coronary Stents Market is a highly fragmented market, with several big and emerging players. Key market players include Medtronic, plc (Ireland), Abbott Laboratories (U.S.), BIOTRONIK SE & Co. KG (Germany), B. Braun Melsungen AG (Germany), Boston Scientific Corporation (U.S.), Biosensors International Group, Ltd. (Singapore), Terumo Corporation (Japan), STENTYS SA (France), MicroPort Scientific Corporation (China), Meril Life Sciences Pvt. Ltd. (India), Vascular Concepts (India), and Translumina GmbH (Germany).

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=77411272